PERSPECTA

News from every angle

← Back to headlines

CSL Signs Licensing Deal with Eli Lilly for Kidney Disease Treatment

CSL has entered into a licensing agreement with Eli Lilly for clazakizumab, a treatment for kidney disease.

17 Feb, 21:26 — 17 Feb, 21:26
PostShare

Sources

Showing 1 of 1 sources
ReutersVery High53d ago

CSL signs licensing deal with Eli Lilly for clazakizumab to treat kidney disease - Reuters

CSL signs licensing deal with Eli Lilly for clazakizumab to treat kidney disease  Reuters

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Truck Carrying Undeclared Fuel Seized at Tabaco Port, Philippines

just now

Philippines Assures Adherence to Laws in Joint Oil Exploration Talks

just now

Philippines Affirms Sovereign Rights in Oil Exploration Agreements

just now